HbA1c and peripheral arterial disease in diabetes -: The atherosclerosis risk in communities study

被引:133
作者
Selvin, E
Wattanakit, K
Steffes, MW
Coresh, J
Sharrett, AR
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21218 USA
[3] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
关键词
D O I
10.2337/diacare.29.04.06.dc05-2018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To assess the relation between HbA(1c) (A1C) and incident peripheral arterial disease (PAD) in a community-based cohort of diabetic adults from the Atherosclerosis Risk in Communities (ARIC) study. A second aim was to investigate whether the association was stronger for severe, symptomatic disease compared with PAD assessed by low ankle-brachial index (ABI). RESEARCH DESIGN AND METHODS - This was a prospective cohort study of 1,894 individuals With diabetes using ARIC visit 2 as baseline (1990-1992) with follow-up for incident PAD through 2002. We assessed the relation between A1C and incident PAD, defined by intermittent claudication, PAD-related hospitalization, or a low ABI (< 0.9). RESULTS - During a mean follow-up of 9.8 years, the crude incidence rates were 2.1 per 1,000 person-years for intermittent. Claudication (n = 41), 2.9 per 1,000 person-years for PAD-related hospitalization (n = 57), and 18.9 per 1,000 person-years for low ABI at visit 3 or 4 (n = 123). The relative risk (RR) (95% CI) of an incident PAD event comparing the second and third tertiles of A1C to the First, respectively, after adjustment for cardiovascular risk factors was strongest for severe, symptomatic forms of disease, e.g., PAD-related hospitalization (RR = 4.56 [1.86-11.18] for the third A1C tertile compared with the first, P trend < 0.001) than for low ABI (RR = .1 64 [0.94-2.87], P trend = 0.08). CONCLUSIONS - We found a positive, graded, and independent association between A1C and PAD risk in diabetic adults. This association was stronger for clinical (symptomatic) PAD, whose manifestations may be related to microvascular insufficiency, than for low ABI. Our results suggest that efforts to improve glycemic control in persons with diabetes may substantially reduce the risk of PAD.
引用
收藏
页码:877 / 882
页数:6
相关论文
共 32 条
[21]   Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes - The atherosclerosis risk in communities study [J].
Selvin, E ;
Coresh, J ;
Golden, SH ;
Boland, LL ;
Brancati, FL ;
Steffes, MW .
DIABETES CARE, 2005, 28 (08) :1965-1973
[22]   Glycaemia (haemoglobin A1c) and incident ischaemic stroke:: the atherosclerosis risk in communities (ARIC) study [J].
Selvin, E ;
Coresh, J ;
Shahar, E ;
Zhang, L ;
Steffes, M ;
Sharrett, AR .
LANCET NEUROLOGY, 2005, 4 (12) :821-826
[23]   Glycemic control and coronary heart disease risk in persons with and without diabetes - The atherosclerosis risk in communities study [J].
Selvin, E ;
Coresh, J ;
Golden, SH ;
Brancati, FL ;
Folsom, AR ;
Steffes, MW .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (16) :1910-1916
[24]   Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus [J].
Selvin, E ;
Marinopoulos, S ;
Berkenblit, G ;
Rami, T ;
Brancati, FL ;
Powe, NR ;
Golden, SH .
ANNALS OF INTERNAL MEDICINE, 2004, 141 (06) :421-431
[25]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[26]  
SIEDEL J, 1983, CLIN CHEM, V29, P1075
[27]   Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study [J].
Stratton, IM ;
Adler, AI ;
Neil, HAW ;
Matthews, DR ;
Manley, SE ;
Cull, CA ;
Hadden, D ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :405-412
[28]   Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].
Turner, RC ;
Holman, RR ;
Cull, CA ;
Stratton, IM ;
Matthews, DR ;
Frighi, V ;
Manley, SE ;
Neil, A ;
McElroy, K ;
Wright, D ;
Kohner, E ;
Fox, C ;
Hadden, D ;
Mehta, Z ;
Smith, A ;
Nugent, Z ;
Peto, R ;
Adlel, AI ;
Mann, JI ;
Bassett, PA ;
Oakes, SF ;
Dornan, TL ;
Aldington, S ;
Lipinski, H ;
Collum, R ;
Harrison, K ;
MacIntyre, C ;
Skinner, S ;
Mortemore, A ;
Nelson, D ;
Cockley, S ;
Levien, S ;
Bodsworth, L ;
Willox, R ;
Biggs, T ;
Dove, S ;
Beattie, E ;
Gradwell, M ;
Staples, S ;
Lam, R ;
Taylor, F ;
Leung, L ;
Carter, RD ;
Brownlee, SM ;
Fisher, KE ;
Islam, K ;
Jelfs, R ;
Williams, PA ;
Williams, FA ;
Sutton, PJ .
LANCET, 1998, 352 (9131) :837-853
[29]  
*U N CAR ARIC COOR, 1987, 10 U N CAR ARIC COOR
[30]   Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals - The atherosclerosis risk in communities study [J].
Vitelli, LL ;
Shahar, E ;
Heiss, G ;
McGovern, PG ;
Brancati, FL ;
Eckfeldt, JH ;
Folsom, AR .
DIABETES CARE, 1997, 20 (09) :1454-1458